Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2161392 | Radiotherapy and Oncology | 2006 | 4 Pages |
Abstract
Within the UK RT01 trial the MRC also funded a quality assurance (QA) programme. This included a planning and dosimetry audit at participating centres using a purpose built phantom. Geometrical setup was visually assessed via field shaping around the phantom GTV (to within the order of 1 mm). Within the phantom, ion chamber positional uncertainties were estimated as 0.6 mm (95% CL, k = 2). This was the basis for ion chamber measurements in a variety of dose gradients around the PTV closely simulating a patient case. The design provides a representative but reproducible system for QA in the prostate radiotherapy process, from CT scan to treatment. Setup errors are not eliminated, but minimised and estimated.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
A. Rollo Moore, A.P. Jim Warrington, Edwin G.A. Aird, A. Margaret Bidmead, David P. Dearnaley,